Evidence map›Paper›PMID 24520336›Full record

ArticlePloS one2014

High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.

Erik Forsblom, Janne Aittoniemi, Eeva Ruotsalainen, Visa Helmijoki, Reetta Huttunen, Juulia Jylhävä, Mikko Hurme, Asko Järvinen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. The evolving landscape ofFrontiers in immunology · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Investigation of plasma cell-free DNA as a potential biomarker in horses.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2022
    Article
  9. Development and validation of a risk score for predicting positivity of blood cultures and mortality in patients with bacteremia and fungemia.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prognostic Power of Pathogen Cell-Free DNA inOpen forum infectious diseases · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Erik ForsblomDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Janne AittoniemiDepartment of Clinical Microbiology, Fimlab Laboratories, Tampere, Finland.
Eeva RuotsalainenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Visa HelmijokiDepartment of Clinical Microbiology, Fimlab Laboratories, Tampere, Finland ; Department of Microbiology and Immunology, School of Medicine, University of Tampere, Tampere, Finland.
Reetta HuttunenDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Juulia JylhäväDepartment of Microbiology and Immunology, School of Medicine, University of Tampere, Tampere, Finland.
Mikko HurmeDepartment of Clinical Microbiology, Fimlab Laboratories, Tampere, Finland ; Department of Microbiology and Immunology, School of Medicine, University of Tampere, Tampere, Finland.
Asko JärvinenDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Helsinki University Hospital · FIFimlab (Finland) · FITampere University · FITampere University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmong patients with bacteraemia or sepsis the plasma cell-free DNA (cf-DNA) biomarker has prognostic value and Pitt bacteraemia scores predict outcome. We evaluated the prognostic value of plasma cf-DNA in patients with Staphylococcus aureus bacteraemia (SAB) treated in the ICU or in the general ward.

methods418 adult patients with positive blood culture for S. aureus were prospectively followed for 90 days. SAB patients were grouped according to ICU treatment: 99 patients were treated in ICU within 7 days of documented SAB whereas 319 patients were managed outside ICU. Pitt bacteraemia scores were assessed at hospital arrival and cf-DNA was measured at days 3 and 5 from positive blood culture.

resultsSAB patients with high Pitt bacteraemia scores and ICU treatment presented higher cf-DNA values as compared to SAB patients with low Pitt bacteraemia scores and non-ICU treatment at both days 3 and 5. Among ICU patients cf-DNA >1.99 µg/ml at day 3 predicted death with a sensitivity of 67% and a specificity of 77% and had an AUC in receiver operating characteristic analysis of 0.71 (p<0.01). The cut-off cf-DNA >1.99 µg/ml value demonstrated a strong association to high Pitt bacteraemia scores (≥ 4 points) (p<0.000). After controlling for all prognostic markers, Pitt bacteraemia scores ≥ 4 points at hospital admission (OR 4.47, p<0.000) and day 3 cf-DNA (OR 3.56, p<0.001) were the strongest factors significantly predicting outcome in ICU patients. cf-DNA at day 5 did not predict fatal outcome.

conclusionHigh cf-DNA concentrations were observed among patients with high Pitt bacteraemia scores and ICU treatment. Pitt bacteraemia scores (≥ 4 points) and cf-DNA at day 3 from positive blood culture predicted death among SAB patients in ICU and were found to be independent prognostic markers. cf-DNA had no prognostic value among non-ICU patients.

Indexed as

AdultBacteremiaBiomarkersC-Reactive ProteinDNAFinlandHumansIntensive Care UnitsPrognosisROC CurveSeverity of Illness IndexStaphylococcal InfectionsStaphylococcus aureusBiomarkersC-Reactive ProteinDNA

Identifiers

PMID24520336
PMCPMC3919733
OpenAlexW1976772193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.